A detailed history of Federated Hermes, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Federated Hermes, Inc. holds 447,606 shares of CRSP stock, worth $17.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
447,606
Previous 447,606 -0.0%
Holding current value
$17.8 Million
Previous $24.2 Million 13.0%
% of portfolio
0.05%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$60.67 - $89.12 $3.67 Million - $5.39 Million
-60,494 Reduced 11.91%
447,606 $30.5 Million
Q3 2023

Nov 13, 2023

SELL
$45.39 - $59.0 $29,866 - $38,822
-658 Reduced 0.13%
508,100 $23.1 Million
Q3 2022

Nov 14, 2022

SELL
$61.1 - $83.78 $4.41 Million - $6.05 Million
-72,160 Reduced 12.42%
508,758 $33.2 Million
Q2 2021

Aug 16, 2021

SELL
$100.84 - $161.89 $594,956 - $955,150
-5,900 Reduced 1.01%
580,918 $94 Million
Q1 2021

May 13, 2021

SELL
$110.72 - $210.04 $5.57 Million - $10.6 Million
-50,282 Reduced 7.89%
586,818 $71.5 Million
Q4 2020

Feb 12, 2021

SELL
$79.67 - $173.23 $10.4 Million - $22.7 Million
-131,150 Reduced 17.07%
637,100 $97.5 Million
Q3 2020

Nov 12, 2020

SELL
$78.5 - $100.64 $24.3 Million - $31.2 Million
-309,750 Reduced 28.73%
768,250 $64.3 Million
Q1 2020

May 13, 2020

SELL
$33.68 - $62.53 $6.19 Million - $11.5 Million
-183,700 Reduced 14.56%
1,078,000 $45.7 Million
Q4 2019

Feb 14, 2020

BUY
$36.68 - $73.13 $14.7 Million - $29.3 Million
400,037 Added 46.43%
1,261,700 $76.8 Million
Q3 2019

Nov 14, 2019

BUY
$40.99 - $52.56 $1.23 Million - $1.58 Million
30,000 Added 3.61%
861,663 $35.3 Million
Q2 2019

Aug 14, 2019

BUY
$35.45 - $48.2 $2.39 Million - $3.25 Million
67,400 Added 8.82%
831,663 $39.2 Million
Q3 2018

Nov 13, 2018

BUY
$44.35 - $65.71 $5.89 Million - $8.73 Million
132,863 Added 21.04%
764,263 $33.9 Million
Q2 2018

Aug 10, 2018

BUY
$42.62 - $73.59 $26.9 Million - $46.5 Million
631,400 New
631,400 $37.1 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.1B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.